Christopher Proudlove

Current Organisation: BIOCLAVIS LIMITED
(some projects in the list below may not be associated with this organisation)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£237,125

May 22 - Jul 24

Translation of TempO-Dx Expanded RASRAF Test markers onto liquid biopsy platform for monitoring treatment resistance in colorectal cancer

Innovate UK award to BIOCLAVIS LIMITED and Christopher Proudlove

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}